Does mitosis-specific marker phosphohistone H3 help the grading of upper tract urothelial carcinomas in cell blocks?

Acta Cytologica

Volumn 56, Issue 3, 2012, Pages 285-288

  Solomides, Charalambos C ^a,b   Birbe, Ruth C ^a,b   Nicolaou, Nicos ^a,b   Bagley, Demetrius ^a,b   Bibbo, Marluce ^a,b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Grading; Phosphohistone H3; Upper tract urothelial carcinoma

Indexed keywords

EOSIN; FORMALDEHYDE; HEMATOXYLIN; HISTONE H3; PARAFFIN; PHOSPHOHISTONE H3; UNCLASSIFIED DRUG;

ARTICLE; CANCER GRADING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOLOGIST; PRIORITY JOURNAL; TRANSITIONAL CELL CARCINOMA;

EID: 84860730476     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000337649     Document Type: Article

References (9)

1. Chen GL, Bagley DH: Ureteroscopic management of upper tract transitional cell carcinoma in patients with normal contralateral kidneys. J Urol 2000; 164: 1173.
2. Elliott DS, Segura JW, Lightner D, et al: Is nephroureterectomy necessary in all casesof upper tract transitional cell carcinoma? Long-term results of conservative endourologic management of upper tract transitional cell carcinoma in individuals with a normal contralateral kidney. Urology 2001; 58: 174.
3. Keeley FX, Bibbo M, Bagley DH: Ureteroscopic treatment and surveillance of upper tract transitional cell carcinoma. J Urol 1997; 157: 1560.
4. Tawfiek E, Bibbo M, Bagley DH: Ureteroscopic biopsy: technique and specimen preparation. Urology 1997; 50: 117.
5. Keeley FX, Kulp DA, Bibbo M, et al: Diagnostic accuracy of ureteroscopic biopsy in upper tract transitional cell carcinoma. J Urol 1997; 157: 33.
6. Mae TK, Teo I, Robertson SJ, Marginean EC, Islam S, Yasdi HM: Immunostaining as a diagnostic and in cytopathologic study of upper urinary tract urothelial carcinoma. Acta Cytol 2009; 53: 611-618.
7. Tapia C, Kutzner H, Mentzel T, Savic S, Baumhoer D, Glatz K: Two mitosis-specific antibodies, MPM-2 and phospho-histone H3 (Ser 28), allow rapid and precise determination of mitotic activity. Am J Surg Pathol 2006; 30: 83-89. (Pubitemid 43740213)
8. Nasr MR, El-Zammar O: Comparison of PHH3, Ki-67, and surviving immunoreactivity in benign and malignant lesions. Am J Dermatopathol 2008; 30: 117-122. (Pubitemid 351441982)
9. Veras E, Malpica A, Deavers MT, Silva EG: Mitosis-specific marker phospho-histone H3 in the assessment of mitotic index in uterine smooth muscle tumors: a pilot study. Int J Gynecol Pathol 2009; 28: 316-321.